CORRECTED-UPDATE 1-German court annuls de facto armoured vehicles export ban to Saudi Arabia




  • In US
  • 2019-12-03 15:16:36Z
  • By Reuters

(In third paragraph, corrects number of vehicles already exported to 20 from 10)

BERLIN, Dec 3 (Reuters) - A German court on Tuesday annulled a de facto export ban that had prevented arms manufacturer Rheinmetall from exporting armoured vehicles to Saudi Arabia, saying German authorities had not followed correct procedures.

In November last year, Germany imposed a ban on future arms sales to Saudi Arabia and temporarily halted deliveries of previously approved kit after Saudi journalist Jamal Khashoggi was murdered in Riyadh's diplomatic mission in Istanbul.

But the court ruled that authorities had failed to follow proper procedures in revoking a previously issued licence allowing the sale of 110 vehicles to Saudi Arabia, 20 of which had already been sent by the end of last October.

A legal source said the company in question was Rheinmetall.

The court said the manner in which the export licence had been revoked indicated that authorities were trying to avoid being forced to pay compensation. The German government can appeal the ruling.

The economy ministry, which is in charge of arms export licences, and Rheinmetall were not immediately available to comment.

(Reporting by Riham Alkousaa; Editing by Tassilo Hummel, Kathrin Jones and Thomas Escritt)

COMMENTS

More Related News

China
China's CanSino in talks for COVID vaccine Phase III trial overseas

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday. China's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it. "We are contacting and Russia, Brazil, Chile and Saudi Arabia (for the Phase III trial) and it's still in discussion," Qiu Dongxu, executive director and co-founder of CanSino, told an anti-viral drug development conference in Suzhou, in eastern China.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US